Showing 1,621 - 1,640 results of 8,337 for search '"Diabetes"', query time: 0.08s Refine Results
  1. 1621
  2. 1622

    Switch to Aflibercept in Diabetic Macular Edema Patients Unresponsive to Previous Anti-VEGF Therapy by Filipe Mira, Manuel Paulo, Filipe Henriques, João Figueira

    Published 2017-01-01
    “…The aim was to evaluate the efficacy of aflibercept in patients with diabetic macular edema (DME) unresponsive to prior anti-VEGF therapy. …”
    Get full text
    Article
  3. 1623
  4. 1624

    Dietary Glycaemic Index and Type 2 Diabetes Mellitus: Potential Modulation of Gut Microbiota by Hanusha Durganaudu, Thubasni Kunasegaran, Amutha Ramadas

    Published 2020-05-01
    “…Diet therapy is often the first-line approach in prevention and management of type 2 diabetes mellitus (T2DM). Adoption of low glycaemic index (GI) diet one of the recent dietary strategies to modulate glycaemic response in individuals with T2DM. …”
    Get full text
    Article
  5. 1625
  6. 1626
  7. 1627
  8. 1628
  9. 1629
  10. 1630
  11. 1631
  12. 1632

    Prediction of MASLD using different screening indexes in Chinese type 2 diabetes mellitus by Mengmeng Hu, Jingyu Yang, Beibei Gao, Zhoulu Wu, Ying Wu, Dandan Hu, Qiong Shen, Lei Chen

    Published 2025-01-01
    “…The primary goal of this study is to assess the ability of different indexes (including VAI, TyG, HOMA-IR, BMI, LAP, WHtR, TyG-BMI, TyG-WC, and TyG-WHtR) to predict MASLD in individuals diagnosed with type 2 diabetes mellitus (T2DM), particularly within the Chinese population. …”
    Get full text
    Article
  13. 1633

    Comparison of Efficiencies of Michigan Neuropathy Screening Instrument, Neurothesiometer, and Electromyography for Diagnosis of Diabetic Neuropathy by Turkan Mete, Yusuf Aydin, Mustafa Saka, Halise Cinar Yavuz, Sule Bilen, Yavuz Yalcin, Berna Arli, Dilek Berker, Serdar Guler

    Published 2013-01-01
    “…This study compares the effectiveness of Michigan Neuropathy Screening Instrument (MNSI), neurothesiometer, and electromyography (EMG) in detecting diabetic peripheral neuropathy in patients with diabetes type 2. …”
    Get full text
    Article
  14. 1634

    Relation Between Glycated Hemoglobin Level and Hearing Loss in Type 2 Diabetic Patients by Mayada ElSherif, Aya Fathey El Sayed Mahfouz, Noha Mohamed Gaber Amin, Hesham Saad Kozou

    Published 2024-11-01
    “…Background: Glycemic control and the efficacy of therapy in diabetic patients with type 2 diabetes during the previous 2-3 months are usually evaluated by measuring the glycated hemoglobin (HbA1c). …”
    Get full text
    Article
  15. 1635

    Hemoglobin mediates the link between the ‘weekend warrior’ physical activity pattern and diabetic retinopathy by Baohua Li, Bobiao Ning, Xinyue Hou, Yipeng Shi, Zefeng Kang

    Published 2025-02-01
    “…Abstract Diabetic retinopathy (DR), the leading cause of vision loss in elderly individuals, coupled with limited treatment options, has prompted efforts to identify modifiable risk factors associated with DR. …”
    Get full text
    Article
  16. 1636

    Insulin Independence in Newly Diagnosed Type 1 Diabetes Patient following Fenofibrate Treatment by Karsten Buschard, Laurits J. Holm, Ulla Feldt-Rasmussen

    Published 2020-01-01
    “…A 19-year-old girl was diagnosed with type 1 diabetes and showing polydipsia and polyuria. She was double autoantibody-positive and had a diabetes-prone tissue type. …”
    Get full text
    Article
  17. 1637
  18. 1638
  19. 1639

    A Randomized Controlled Trial of Conbercept Pretreatment before Vitrectomy in Proliferative Diabetic Retinopathy by Xiaochun Yang, Jianbiao Xu, Ruili Wang, Yan Mei, Huo Lei, Jun Liu, Ting Zhang, Haiyan Zhao

    Published 2016-01-01
    “…To determine the efficacy and safety of preoperative intravitreal conbercept (IVC) injection before vitrectomy for proliferative diabetic retinopathy (PDR). Methods. 107 eyes of 88 patients that underwent pars plana vitrectomy (PPV) for active PDR were enrolled. …”
    Get full text
    Article
  20. 1640